Team Style
Founder
Prof. Wei Jia
- 2013-2019 Tenured and Full Professor at University of Hawaii, and Associate Director of the University of Hawaii Cancer Center
- 2008-2013 Tenured and Full Professor at the University of North Carolina at Greensboro and Co-Director of UNCG Center for Translational Biomedical Research
- 2003-2008 Professor and Vice Dean for Research, School of Pharmacy, Shanghai Jiao Tong University
- 2001-2003 Professor and Executive Vice Dean at College of Pharmaceutical Science, Tianjin University
- 1998-2003 Founder, Chairman, and CEO of Wofen (Tianjin) Pharmaceutical Co., Ltd.
Prof. Wei Jia currently serves as a chair professor at the School of Chinese Medicine, Hong Kong Baptist University, and director of the Hong Kong Traditional Chinese Medicine Phenome Research Centre (HKPR), who is also a adjunct professor at the Shanghai Jiao Tong University School of Medicine.
Prof. Jia has been specializing in scientific research and industrialization in the pharmacy and medical sectors for over two decades. He has founded and assisted the operation of an array of academic or research and development (R&D) institutes funded by businesses, including medical centers for discipline-based cross-transformation research, clinical multi-omics research platforms, and R&D institutes of traditional Chinese medicines and natural drugs.
He has published over 500 scientific papers on international academic periodicals, which have been quoted for more than 37,000 times, with an h-index of 92 on Google Scholar, and 10 academic books, with the ownership of 20 invention patents. As the chief scientist, Jia led and completed numerous scientific research programs, including National Basic Research Program of China (973 Program), NIH R01 project, NCI/NIH U01 project, and many others. His research findings were published on top-level academic journals, such as Science, Nature Reviews Drug Discovery, Cancer Cell, Science Translational Medicine, Blood, Proceedings of the National Academy of Sciences USA (PNAS), among other high-level international learned periodicals. Finding of his study on nephrotoxicity among children caused by interaction between milk-based infant formula contaminated with melamine and intestinal bacteria in children was on the list of Science's Top 10 Breakthroughs of 2013.
Core Team
Guoxiang Xie
Co-founder/Chief Operating Officer
Jingchao Lin
Chief Marketing Officer
Kejun Zhou
R&D Director
专注 创新 快乐 成长
Gathering world’s top scientists and medical elites from metabolomics and mass spectrometry, clinical medicine, bioinformatics, and more sectors, HMI focuses on turning its patents and scientific research payoffs into products, and steers constant innovation in precision medicine and diagnostics. Its founding team boasts nearly two decades of world-class scientific research experience in the metabolomics sector as well as dominant innovations in the world, hence laying a solid foundation of innovation and talent reserve for China based on metabolomics and biomedicine .